48.04 USD
↘ 0.17 (0.35%)AT CLOSE (11:59 AM EDT)
Supernus Pharmaceuticals, Inc.
SUPNNASDAQ • USD
48.05
↗ 0.01 (0.01%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
48.05
↗ 0.01 (0.01%)
Market: CLOSED
Supernus Pharmaceuticals, Inc. (SUPN) is currently trading at $48.05. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place SUPN at a fair price relative to peers.
Technical & fundamental data as of Jul 17, 2026.
Open?$48.15
High?$49.06
Low?$47.90
Prev. Close?$48.21
Volume?439.4K
Avg. Volume?867.3K
VWAP?$48.39
Rel. Volume?0.51x
Bid / Ask
Bid?$41.86 × 100
Ask?$57.85 × 100
Spread?$15.99
Midpoint?$49.86
Valuation & Ratios
Market Cap?2.8B
Shares Out?58.0M
Float?55.4M
Float %?95.4%
P/E Ratio?N/A
P/B Ratio?2.60
EPS?-$0.50
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Employees
778
Market Cap
2.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-05-01
Address
9715 KEY WEST AVENUE
ROCKVILLE, MD 20850
Phone: 301-838-2500
ROCKVILLE, MD 20850
Phone: 301-838-2500
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?98
Momentum?87
Short Sent.?24
Piotroski F-Score?2/9Weak
Altman Z-Score?5.11Safe
Confidence?55%Low
Short InterestHigh
Short % of Float?12.90%High
Short Interest?7.1M
Days to Cover?7.0
Free Float55.4M
Avg Daily Volume1.0M
Settlement Date2026-06-30
Financial Health
Current Ratio?1.96Adequate
Quick Ratio?1.72Adequate
Cash Ratio?0.49Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.60CHEAP▾
Peers100
S&P62
P/S?3.60FAIR▾
Peers100
S&P43
P/FCF?34.0FAIR▾
Peers100
S&P23
EV/EBITDA?66.4HIGH▾
Peers100
S&P3
EV/Sales?3.36FAIR▾
Peers100
S&P56
Returns & Efficiency
ROE?-2.7%WEAK▾
S&P13
ROA?-1.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$82.2M
Enterprise Value?$2.6B
Fundamentals ratios updated end of day